Mind Lab Pro Review: Does the 30-Day Study Match v4?

Bottom Line: What a Buyer Can and Cannot Conclude

Mind Lab Pro v4 is a multi-ingredient dietary supplement sold in plant-based pullulan NutriCaps.

One label serving is two capsules. The container provides 30 servings.

The formula includes three B vitamins, citicoline, Bacopa monnieri, organic lion’s mane mushroom, phosphatidylserine, N-acetyl-L-tyrosine, L-theanine, Rhodiola rosea, and maritime pine bark extract.

The official page gives an individual amount for all 11 entries. It also supplies a branded form, source, plant part, or extract standard for several of them.

That disclosure helps a buyer see what the official page says is in one serving.

It does not establish that the combination improves memory, focus, mood, motivation, or any other outcome.

The best formula-level evidence in the packet is a study involving 49 healthy adults aged 20–68. Thirty-six participants were in the experimental group. Thirteen were in the control group.

The study lasted 30 days. Its design was described as pseudo-randomized, double-blinded, placebo-controlled, and pre/post.

The experimental group improved across all assessed memory subtests. Between-group differences were reported for immediate recall and delayed recall.

Those are favorable findings. They still require restraint.

An improvement inside the experimental group is not automatically proof that the supplement caused every change. The between-group comparisons are more useful because they compare the experimental and control groups.

Even those comparisons do not settle the current buying question.

The abstract identifies a plant-based Mind Lab Pro supplement but does not name v4. It does not report the tested form or dose.

We therefore cannot confirm that the participants took the same formula, in the same form and amount, that appears on the current v4 page.

The study also concerned memory measures. It does not verify every part of the manufacturer’s broader focus, clarity, mood, and motivation positioning.

The practical conclusion is narrow.

Mind Lab Pro v4 offers a stimulant-free format and unusually inspectable amounts within the supplied record. It also has one relevant finished-product study record.

It does not have a confirmed exact match between that study and the current v4 product in the supplied evidence.

That makes it a more plausible consideration for a buyer who values label detail and accepts unresolved trial matching.

It is a weaker choice for someone who requires a large, long-term trial naming the exact v4 version, form, and dose.

What Exactly Is Mind Lab Pro v4?

The product covered here is Mind Lab Pro v4.

Keeping that version name visible matters. A study of an unidentified Mind Lab Pro version cannot automatically be treated as a study of v4.

According to the official Mind Lab Pro product page, the product comes in NutriCaps made from plant-based pullulan.

The official serving is two NutriCaps. The container lists 30 servings.

The official directions say to take two capsules in the morning before eating. They allow another two capsules around lunchtime if required.

The page also states that the product contains no caffeine or stimulants.

That stimulant statement is a product fact from the official page. It is not evidence that every user will have the same subjective response.

The manufacturer describes v4 as a “Universal Nootropic.” A nootropic is a product positioned for cognitive support.

The company says the formula is designed to support focus, clarity, memory, mood, motivation, and more.

Those are manufacturer-attributed claims. The official page shows that the company makes them. It does not independently prove them.

The product page also claims that Mind Lab Pro v4 has enhanced brainpower in multiple double-blind, placebo-controlled human trials.

The packet contains only one finished-product study record. That record does not identify v4.

This review can therefore report the manufacturer’s multiple-trial claim, but it cannot independently confirm that multiple supplied trials tested the current v4 formula.

The manufacturer further states that the product is third-party tested for purity and potency.

No laboratory reports, methods, tested batch identifiers, or results appear in the packet.

The third-party-testing statement must therefore remain a manufacturer claim rather than an independently verified conclusion.

Ingredients in the Full Two-Capsule Formula

Every amount below applies to the official two-NutriCaps serving.

Ingredient	Amount	Exact label detail supplied
Vitamin B6	2.5 mg	From NutriGenesis
Vitamin B9	100 mcg	From NutriGenesis
Vitamin B12	7.5 mcg	From NutriGenesis
Citicoline	250 mg	As Cognizin
Bacopa monnieri	150 mg	Full-spectrum aerial-parts extract; 24% bacosides with 9 bioactives
Organic lion’s mane mushroom	500 mg	Mycelium and fruit
Phosphatidylserine	100 mg	From sunflower lecithin
N-acetyl-L-tyrosine	175 mg	No additional qualifier supplied
L-theanine	100 mg	No additional qualifier supplied
Rhodiola rosea	50 mg	Root; 3% rosavins and 1% salidrosides
Maritime pine bark extract	75 mg	95% proanthocyanidins

Here, mg means milligrams. Mcg means micrograms.

NutriGenesis and Cognizin are branded names shown in the official product information. A branded name identifies how an ingredient is presented on the label. It does not establish a clinical benefit.

The Bacopa entry is more specific than a plant name alone. It identifies an aerial-parts extract, 24% bacosides, and nine bioactives.

The Rhodiola entry identifies the root and gives percentages for rosavins and salidrosides.

The maritime pine bark entry states 95% proanthocyanidins.

These percentages describe the labeled materials. They are not percentages of people who improved. They are not measures of clinical effectiveness.

The lion’s mane entry also deserves product-specific attention. It lists mycelium and fruit rather than giving only the mushroom name.

That detail would matter when matching the product to research because a study would need to disclose comparable material before a close match could be established.

No ingredient-level human studies were supplied for this review.

As a result, the packet cannot show whether 250 milligrams of Cognizin citicoline matches a studied dose. It cannot show whether the 150-milligram Bacopa extract matches the form, standardization, dose, population, and duration used in a human trial.

The same problem applies to the lion’s mane material, sunflower-derived phosphatidylserine, N-acetyl-L-tyrosine, L-theanine, Rhodiola root extract, maritime pine bark extract, and the three B vitamins.

This is not a finding that the ingredients fail.

It is a finding that ingredient-level matching is impossible from the supplied packet.

Even a close ingredient match would have a firm boundary. Research on isolated citicoline would remain citicoline research. It would not prove the effect of citicoline when combined with the other ten entries in Mind Lab Pro v4.

The same rule applies to every component.

This product is purchased as one combined formula. Formula-level conclusions require evidence on the finished formula, with enough product detail to confirm the match.

That is why the finished-product study matters more to this decision than the familiarity of any individual ingredient name.

The 30-Day Study: Relevant, but Not a Confirmed v4 Match

The packet’s primary study source is the PubMed record for PMID 37194920.

It concerns a finished Mind Lab Pro supplement.

That is a meaningful strength in relevance. The researchers did not study only one ingredient and then assume that the complete product would behave the same way.

The remaining limitations are substantial.

Study question	What the supplied record says	What that means for v4
Was Mind Lab Pro tested?	Yes, a plant-based Mind Lab Pro supplement was identified	The product family is relevant
Was v4 named?	No	The current version cannot be confirmed as the tested version
Was the tested form reported?	No	A form match cannot be checked
Was the dose reported?	No	A dose match cannot be checked
Who participated?	49 healthy adults aged 20–68	The record applies to a small healthy-adult sample, not every population
How were groups divided?	36 experimental and 13 control	The groups were unequal
How long did it run?	30 days	The findings are short term
What was the design?	Pseudo-randomized, double-blinded, placebo-controlled pre/post	The record uses stronger controls than an uncontrolled report, but the supplied abstract does not explain the assignment process
What improved?	The experimental group improved in all assessed memory subtests	This is a within-group finding
What differed between groups?	Immediate recall and delayed recall	These are the supplied between-group findings
Was funding reported?	Not in the supplied abstract	Funding cannot be assessed from this record

A pre/post study measures participants before and after an intervention period.

A placebo-controlled study compares the tested supplement with a comparison product. This helps separate product-related findings from changes that might occur for other reasons.

Double-blinding is intended to keep treatment assignment hidden from specified people during the study. The supplied abstract does not identify exactly who was blinded.

The study is described as pseudo-randomized. The supplied record does not explain how participants were assigned to the experimental and control groups.

That missing detail prevents a deeper assessment of the assignment method.

The unequal group sizes also matter. The experimental group contained 36 participants, while the control group contained 13.

The study’s total of 49 completers and its 30-day duration make it limited evidence. They do not erase the reported findings, but they narrow the confidence and scope of any conclusion.

The findings themselves need two separate sentences.

First, the experimental group improved significantly in all assessed memory subtests.

Second, between-group differences were reported for immediate recall and delayed recall.

Those statements do different jobs.

The first describes changes within the experimental group. The second describes differences between the experimental and control groups.

Neither statement should be expanded into a promise of universal cognitive improvement.

The supplied study record reports memory outcomes. It does not establish that Mind Lab Pro v4 improves mood, motivation, work output, resistance to interruption, or every form of focus.

It also does not provide an individual onset time.

A 30-day study is not proof that a user will notice a benefit on day 30. It does not show that everyone will respond. It does not establish what happens with longer use.

The population creates another clear boundary.

The participants were healthy adults aged 20–68. The study should not be presented as evidence that the product treats, prevents, or reverses a disease.

The central matching problem remains the most important limitation for a current buyer.

The official product under review is Mind Lab Pro v4 in NutriCaps, with a detailed two-capsule label.

The study abstract does not identify v4, the tested form, or the dose.

Without those details, direct transfer to the current formula cannot be confirmed.

The most accurate summary is therefore specific:

One short study of a finished Mind Lab Pro supplement reported favorable findings on assessed memory measures in healthy adults. The supplied abstract does not provide enough product detail to establish that the findings belong to the current v4 formula.

Manufacturer Positioning Versus Supplied Proof

Mind Lab Pro’s official page presents a broad cognitive-support case.

The company calls v4 a universal nootropic and says it is designed to support focus, clarity, memory, mood, motivation, and more.

The supplied finished-product study is narrower.

It reports memory findings. Those findings are relevant to the manufacturer’s memory positioning.

They do not confirm the full list of cognitive areas.

Memory is not a substitute term for mood. Immediate recall is not the same outcome as motivation. Delayed recall does not by itself establish mental clarity or sustained focus.

The distinction is especially important in a multi-ingredient product. A long formula and wide positioning can make several outcomes appear connected even when the supplied study measured only a smaller set.

This review does not assign a separate proven role to each ingredient.

No ingredient studies were supplied. The complete formula also cannot be matched to v4 in the finished-product abstract.

The manufacturer’s claim about multiple double-blind, placebo-controlled human trials remains attributed for the same reason.

One supplied record cannot independently verify a claim about multiple trials. Because the supplied study abstract omits the version, form, and dose, this review cannot confirm that the study product matched v4.

The purity-and-potency testing claim has a similar boundary.

The manufacturer says third-party testing occurs. The packet contains no test report that would allow an independent check of the tested batch, methods, thresholds, or results.

This is not evidence that testing did not occur.

It means the claim is not independently demonstrated in the supplied material.

No verified user-outcome evidence was supplied.

This review therefore does not use anecdotal claims to bridge the evidence gaps.

Directions, Serving Use, and the $69 Price Snapshot

The official directions begin with two capsules in the morning before eating.

That is one full label serving.

The directions also allow a further two capsules around lunchtime if required.

That optional use is another full serving. It would make the 30-serving container run out sooner than use limited to one serving each day.

The packet does not establish how often a buyer would choose the additional serving.

It therefore does not support one universal statement about how long every container will last in actual use.

This is a practical tradeoff because all label amounts are stated for two NutriCaps.

A reader comparing the formula with the price should first decide whether the intended routine is the morning serving alone or includes the optional lunchtime serving.

The official page listed a one-time price of $69 in the evidence snapshot dated August 30, 2026.

That price may change. It is not a permanent offer.

Purchase detail	What is verified
Product	Mind Lab Pro v4
Listed one-time price	$69 US dollars in the dated snapshot
Servings per container	30
Label serving	Two NutriCaps
Optional direction	A further two capsules around lunchtime if required
Guarantee	No verified terms supplied
Shipping	No verified terms supplied
Bundles	No verified terms supplied
Subscription	No verified terms supplied
Inventory	No live status supplied
Scarcity or deadline	None verified

The absence of verified guarantee terms means this review cannot promise a refund period or return process.

The same restraint applies to shipping charges, bundles, subscriptions, stock status, and deadlines.

A reader can check the current official page before ordering. The useful checks are the version name, supplement facts, directions, current price, and current purchase terms.

The official page’s no-caffeine statement may also influence routine fit.

Someone trying to avoid caffeine may value that feature. The statement does not predict how the complete formula will feel to an individual.

It also does not establish an immediate cognitive effect without caffeine.

Safety Questions the Study and Label Do Not Resolve

Mind Lab Pro v4 is a dietary supplement.

The US Food and Drug Administration guidance on dietary supplements states that the Food and Drug Administration, or FDA, does not approve dietary supplements for safety and effectiveness before they are sold.

The FDA also does not approve supplement labeling before sale.

This does not establish that Mind Lab Pro v4 is unsafe.

It means that being available for purchase should not be confused with FDA approval of this product’s safety, effectiveness, or labeling.

The FDA advises consumers to discuss supplement benefits and risks with a health care professional.

Supplements may interact with medications. They may interfere with laboratory tests. They may also have dangerous effects during surgery.

The agency advises taking supplements only as described on the label. It also says not to assume that a product described as natural is safe.

These points are relevant to Mind Lab Pro v4 because it combines 11 listed ingredients in one serving.

The packet does not provide a detailed v4 adverse-event table. It also does not supply a finished-product safety record that can be matched to the current version, form, and dose.

The manufacturer’s third-party-testing claim does not fill that gap without the underlying reports.

This review therefore cannot declare the formula safe for everyone.

A health care professional is the appropriate person to consider an individual’s medications, laboratory testing, planned surgery, and health history.

The official directions should also remain directions rather than personalized advice.

Two capsules in the morning before eating is the manufacturer’s stated routine. The optional lunchtime serving is also part of the manufacturer’s directions.

Neither direction establishes that more capsules will produce a better outcome for a particular person.

Who May Find the Evidence Sufficient—and Who May Not

Mind Lab Pro v4 may interest someone whose first requirement is a caffeine-free cognitive supplement with individually listed ingredient amounts.

The official page satisfies that label-level preference within the supplied record.

It may also interest a reader who gives added weight to the existence of a finished-product study, even though the study cannot be matched securely to v4.

That reader would need to accept several limits at once.

The trial was short. It involved 49 healthy adults. The groups were unequal. The design was described as pseudo-randomized. The supplied abstract omits the current version name, form, and dose.

The findings also concern memory rather than every area in the manufacturer’s positioning.

Mind Lab Pro v4 may be worth examining if:

• You want a formula that the official page says contains no caffeine or stimulants.

• You value exact two-capsule amounts for all 11 listed ingredients.

• You understand that branded forms and extract standards are label details, not proof of benefit.

• You view the 30-day study as relevant but incomplete formula-level evidence.

• You accept that the study cannot be confirmed as a test of v4.

• You are prepared to check the current price and purchase terms rather than relying on the dated snapshot.

• You can discuss personal supplement risks with a health care professional when relevant.

It is a weaker fit if:

• You require a trial that names Mind Lab Pro v4 and reports the tested form and dose.

• You require a large or long-term finished-product study.

• You expect guaranteed changes in focus, clarity, mood, motivation, or real-world performance.

• You want a verified immediate onset.

• You need independently supplied purity and potency reports before deciding.

• You need verified guarantee, shipping, bundle, subscription, or inventory terms from this review.

• A health care professional has advised you to avoid the formula or one of its ingredients.

The decision is not simply whether the ingredient list looks comprehensive.

It is whether exact label disclosure, stimulant status, a limited finished-product study, and unresolved v4 matching together meet your evidence standard.

Daily Intel VSL Strategy: Put the Formula on Trial

Daily Intel would test an original evidence-hearing concept called “Put the Formula on Trial.”

If a finished capsule has not been clearly matched to the research, how much should a shelf full of impressive ingredient names persuade you?

That is the question at the center of this Mind Lab Pro review.

Not whether you recognize lion’s mane.

Not whether citicoline sounds scientific.

Not whether a long formula looks more advanced than a short one.

The real question is simpler.

What can we verify about Mind Lab Pro v4, and where does the evidence stop?

So let’s put the formula on trial.

A video sales letter, or VSL, is a structured promotional video. What follows is Daily Intel’s private editorial model.

It is not a script, advertisement, campaign, transcript, or sales result attributed to Mind Lab Pro.

It does not imply that the manufacturer used this concept. It does not predict conversions or personal outcomes.

Hook

The opening would put the version question ahead of the ingredient names:

“Mind Lab Pro has a finished-product study. But did that study test the same v4 capsules now on the official page?”

The next visual would place two evidence cards side by side.

The current-product card would show Mind Lab Pro v4, a two-NutriCaps serving, 11 listed amounts, and no caffeine or stimulants according to the official page.

The study card would show 49 healthy adults, 30 days, 36 experimental participants, 13 controls, and reported memory findings.

Three fields would remain visibly blank on the study card: version, form, and dose.

The hook would not claim that the product fails because those fields are missing.

It would establish the specific question a careful buyer needs answered.

The opening price line would remain dated:

“The official page listed a one-time price of $69 in the August 30, 2026 evidence snapshot. Before spending it, decide how much an unresolved study match matters to you.”

That creates a concrete decision without inventing urgency, scarcity, or a hidden threat.

Lead

The lead would begin with the attraction of the current label.

Mind Lab Pro v4 does not present only a short list of ingredient names. It gives amounts for three B vitamins, citicoline, Bacopa, lion’s mane, phosphatidylserine, N-acetyl-L-tyrosine, L-theanine, Rhodiola, and maritime pine bark extract.

Several entries include additional detail.

Citicoline appears as Cognizin. Bacopa is described as a full-spectrum aerial-parts extract with 24% bacosides and nine bioactives. Lion’s mane lists mycelium and fruit. Rhodiola identifies the root and its rosavin and salidroside percentages.

This specificity makes the formula easier to inspect.

It can also tempt a viewer to treat detail as proof.

The lead would interrupt that shortcut:

“A precise label tells you what the official page says is in two capsules. It does not tell you whether this complete combination produced the outcome you want.”

The viewer would then receive a simple promise about the editorial process, not the product:

“We will check four things: the current version, the disclosed serving, the finished-product study, and the gap between the two.”

Mechanism

The mechanism would be a product-match test rather than a biological theory.

Step one is the version lock.

The offered product is Mind Lab Pro v4. Any research applied to that product should identify the version clearly enough to assess whether it matches v4.

Step two is the serving lock.

The current supplement facts apply to two NutriCaps. The official routine begins with two capsules in the morning before eating and allows another two around lunchtime if required.

A trial match should disclose the tested dose. The supplied abstract does not.

Step three is the form lock.

The current product uses plant-based pullulan NutriCaps. The study abstract describes a plant-based Mind Lab Pro supplement but does not report the tested form.

The words plant-based do not establish that the form matched the current capsules.

Step four is the outcome lock.

The manufacturer positions v4 around focus, clarity, memory, mood, motivation, and more.

The supplied study reports memory findings. The execution would keep those outcome categories separate.

A result for immediate or delayed recall would not be rewritten as proof of mood, motivation, or universal cognitive performance.

The mechanism would end with one rule:

“A study is strongest for this buying decision when the product version, formula, form, dose, population, duration, and measured outcome all fit. Here, several parts fit only partly or remain unknown.”

Story

The viewer would become the reviewer examining three exhibits.

Exhibit one is the current official page.

It identifies Mind Lab Pro v4. It lists 30 servings per container and two NutriCaps per serving. It provides exact amounts for 11 ingredients and states that the product has no caffeine or stimulants.

The formula receives clear credit for disclosure.

Then the reviewer asks what that page can prove.

It can establish the official identity, label, directions, displayed price, and manufacturer claims.

It cannot independently establish effectiveness.

Exhibit two is the manufacturer’s wider case.

Mind Lab Pro calls v4 a universal nootropic. The company says it is designed to support focus, clarity, memory, mood, motivation, and more.

It also claims multiple double-blind, placebo-controlled human trials and third-party testing for purity and potency.

The story would keep the speaker visible beside every claim.

The manufacturer says these things. The packet does not independently establish the full breadth of the cognitive positioning, multiple current-v4 trials, or laboratory results.

Exhibit three is the published study record.

This is the strongest proof exhibit because it concerns a finished Mind Lab Pro supplement rather than an isolated component.

The study involved 49 healthy adults aged 20–68. Thirty-six were in the experimental group. Thirteen were in the control group. The duration was 30 days.

The experimental group improved in all assessed memory subtests. Between-group differences were reported for immediate and delayed recall.

The execution would present those findings plainly before turning to the limits.

The design was described as pseudo-randomized, double-blinded, placebo-controlled, and pre/post. The supplied abstract does not explain the assignment method or identify exactly who was blinded.

The groups were unequal. Follow-up lasted 30 days.

Most importantly, the abstract does not identify v4, the tested form, or the dose.

The narrative turn would be measured:

“The study belongs in the conversation. It does not close the conversation.”

Proof

The proof section would use three levels.

Level one is verified current-product information.

The official page supports the v4 identity, pullulan NutriCaps format, two-capsule supplement-facts serving, 30 servings per container, ingredient amounts, directions, stimulant statement, and dated $69 price.

Level two is reported finished-product research.

The PubMed abstract supports the study design description, healthy-adult population, group sizes, 30-day duration, and reported memory findings.

Level three is the transfer test.

This is where certainty stops. The study record does not disclose enough information to verify that its product was the current v4 formula in the current form and dose.

The proof section would avoid an ingredient montage that assigns a proven mental function to every capsule component.

No ingredient-level studies were supplied. Even matched ingredient studies would not establish that the finished 11-ingredient combination works.

There would also be no anecdotal outcome sequence.

No verified user-outcome evidence was supplied. Creating such evidence would be fiction.

Objections

The first objection would be: “Doesn’t the finished-product study prove v4 works?”

The answer would be precise.

It is more relevant than an isolated-ingredient study because it tested a Mind Lab Pro supplement. The abstract does not name v4 or report the form and dose, so it cannot confirm an exact current-product match.

The second objection would be: “Does the detailed formula prove that the doses are effective?”

No.

The label supplies exact amounts. The packet supplies no ingredient trials that would allow form, dose, population, and duration matching.

Even a close ingredient match would remain evidence about that ingredient, not the complete formula.

The third objection would be: “Will it improve focus, mood, and motivation too?”

The manufacturer positions the product across those areas.

The supplied finished-product study reports memory findings. It should not be expanded to outcomes it did not establish.

The fourth objection would be: “Will I feel something immediately?”

No verified onset time appears in the packet.

The official page’s no-caffeine statement does not predict a specific sensation or personal result.

The fifth objection would be: “Does third-party tested mean the product is independently verified here?”

No.

It means the manufacturer makes a third-party-testing claim. The packet does not include laboratory reports or results for independent review.

The sixth objection would concern safety.

The response would explain that the FDA does not approve dietary supplements for safety and effectiveness before sale. It would direct the viewer to discuss medications, laboratory tests, surgery, and personal risks with a health care professional.

Offer

The offer section would be deliberately quiet.

“As of the August 30, 2026 evidence snapshot, the official page listed a one-time price of $69. Prices and terms may change.”

The visual would show 30 servings per container and two NutriCaps per label serving.

It would also show the optional further two capsules around lunchtime. That optional second serving would use the container more quickly.

No guarantee would be promised because no verified guarantee terms were supplied.

No shipping rate, bundle discount, subscription saving, inventory claim, countdown, or low-stock warning would be added.

The offer would be presented as a dated fact set rather than a pressure sequence.

Call to Action

A call to action, or CTA, tells the viewer what to do next.

This CTA would be a verification decision:

“Open the current official page. Confirm that the product still says Mind Lab Pro v4. Check the two-capsule label, directions, current price, and current purchase terms. Decide whether the caffeine-free format and disclosed amounts suit your preferences.”

The second part would address the evidence standard:

“Then decide whether one favorable 30-day memory study is enough for you when its abstract does not identify the version, form, or dose.”

The final line would summarize the strategy:

“Give the label credit for what it reveals. Give the study credit for what it reports. Do not pretend the missing match has been solved.”

That is the VSL strategy Daily Intel would test.

Its persuasion comes from a product-specific tension. Mind Lab Pro v4 has a detailed current label and a relevant finished-product study, but the supplied records do not securely connect them.

The strategy makes that unresolved connection the decision point. It does not invent a manufacturer campaign, buyer result, clinical outcome, urgency device, or guarantee.

Frequently Asked Questions

Q: Does Mind Lab Pro v4 contain caffeine?

A: No. The official product page states that Mind Lab Pro v4 contains no caffeine or stimulants.

Q: Was the exact Mind Lab Pro v4 formula tested in the supplied study?

A: That cannot be confirmed. The abstract identifies a plant-based Mind Lab Pro supplement but does not report the version, form, or dose.

Q: What did the 30-day Mind Lab Pro study find?

A: The experimental group improved across all assessed memory subtests. Between-group differences were reported for immediate and delayed recall. The result is limited by the pseudo-randomized design, 49-person sample, unequal groups, 30-day duration, and missing version, form, and dose details.

Q: Does the study prove benefits for focus, mood, or motivation?

A: No. The supplied abstract reports memory findings. The broader focus, clarity, mood, and motivation positioning remains attributed to the manufacturer.

Q: How should Mind Lab Pro v4 be taken?

A: The official directions say to take two capsules in the morning before eating. They allow a further two capsules around lunchtime if required.

Q: How much does Mind Lab Pro cost?

A: The official page listed a one-time price of $69 in the August 30, 2026 evidence snapshot. That is a dated price, not a permanent promise.

Q: Is third-party testing independently verified here?

A: No. The manufacturer states that the product is third-party tested for purity and potency, but the packet does not include laboratory reports or test results.

Sources and Evidence Notes

Evidence card: The official Mind Lab Pro product page establishes the current v4 identity, NutriCaps format, 30 servings, two-capsule ingredient amounts, directions, no-caffeine statement, and dated listed price. It also records the manufacturer’s cognitive, trial, and third-party-testing claims. It does not independently prove those claims.

Evidence card: The PubMed record for PMID 37194920 describes the supplied 30-day finished-product study involving 49 healthy adults. It supports the reported design, group sizes, and memory findings. Its abstract does not identify v4 or report the tested form, dose, or funding.

Evidence card: The Food and Drug Administration dietary supplement guidance provides the regulatory and safety context used here. It explains that supplements are not approved by the FDA for safety and effectiveness before sale and advises consumers to consider medication interactions, laboratory tests, and surgery with a health care professional.

No ingredient-level study, independent laboratory report, verified guarantee, user-outcome evidence, or additional external source was supplied.

Final Verdict: A Detailed Label With an Unresolved Study Match

Mind Lab Pro v4 presents a clear current label within the supplied evidence.

The official page lists exact amounts for 11 ingredients in a two-capsule serving. Several entries also provide a branded form, ingredient source, plant part, or extract standard.

The page states that the product contains no caffeine or stimulants.

Those are useful product facts. They make the formula easier to inspect and compare.

They do not establish effectiveness.

The finished-product study is the strongest efficacy-related evidence in the packet. It involved 49 healthy adults over 30 days.

The experimental group improved across all assessed memory subtests. Between-group differences were reported for immediate and delayed recall.

The study remains limited by its pseudo-randomized design, unequal group sizes, small number of completers, and short duration.

For this specific buying decision, the missing product details matter even more.

The abstract does not identify Mind Lab Pro v4. It does not report the tested form or dose.

An exact transfer to the current v4 formula therefore cannot be confirmed.

The findings should also remain tied to memory. They do not verify the manufacturer’s full positioning around focus, clarity, mood, and motivation.

The official page’s one-time price was $69 in the August 30, 2026 evidence snapshot. No verified guarantee, live inventory status, shipping term, bundle, or subscription detail was supplied.

Mind Lab Pro v4 may suit a reader who prioritizes a stimulant-free format, exact label amounts, and some finished-product research while accepting an unresolved version match.

It is less convincing for a reader who requires direct evidence on the exact v4 formula, form, and dose or expects a guaranteed result across several cognitive areas.

The cleanest decision rule is this:

Treat the label as evidence of what the official page says the current product contains. Treat the study as limited evidence about an unidentified Mind Lab Pro version. Do not merge the two into certainty that the supplied records cannot support.

This article is for informational and educational purposes only. It is not medical advice. Daily Intel is not affiliated with or endorsed by Mind Lab Pro.